Cargando…

Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury

Epoxyeicosatrienoic acids (EETs) contribute to blood pressure regulation leading to the concept that EETs can be therapeutically targeted for hypertension and the associated end organ damage. In the present study, we investigated anti-hypertensive and kidney protective actions of an EET analog, EET-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hye Khan, Md. Abdul, Falck, John R., Manthati, Vijaya L., Campbell, William B., Imig, John D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172029/ https://www.ncbi.nlm.nih.gov/pubmed/25295006 http://dx.doi.org/10.3389/fphar.2014.00216

Ejemplares similares

Epoxyeicosatrienoic Acid Analog EET-A Blunts Development of Lupus Nephritis in Mice
por: Hye Khan, Md. Abdul, et al.
Publicado: (2019)

Erratum on: Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury
Publicado: (2014)

Epoxyeicosatrienoic Acid Analog Decreases Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition
por: Skibba, Melissa, et al.
Publicado: (2017)

Development of Epoxyeicosatrienoic Acid Analogs with in Vivo Anti-Hypertensive Actions
por: Imig, John D., et al.
Publicado: (2010)

Epoxyeicosatrienoic Acid Analog and 20-HETE Antagonist Combination Prevent Hypertension Development in Spontaneously Hypertensive Rats
por: Baranowska, Iwona, et al.
Publicado: (2022)

Epoxyeicosatrienoic acid analog EET-B attenuates post-myocardial infarction remodeling in spontaneously hypertensive rats
por: Neckář, Jan, et al.
Publicado: (2019)

Kidney-Targeted Epoxyeicosatrienoic Acid Analog, EET-F01, Reduces Inflammation, Oxidative Stress, and Cisplatin-Induced Nephrotoxicity
por: Imig, John D., et al.
Publicado: (2021)

Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive Ren-2 Transgenic Rats
por: Hrdlička, Jaroslav, et al.
Publicado: (2019)

Early Renal Vasodilator and Hypotensive Action of Epoxyeicosatrienoic Acid Analog (EET-A) and 20-HETE Receptor Blocker (AAA) in Spontaneously Hypertensive Rats
por: Walkowska, Agnieszka, et al.
Publicado: (2021)

Effects of Epoxyeicosatrienoic Acid-Enhancing Therapy on the Course of Congestive Heart Failure in Angiotensin II-Dependent Rat Hypertension: From mRNA Analysis towards Functional In Vivo Evaluation
por: Kala, Petr, et al.
Publicado: (2021)

Inside epoxyeicosatrienoic acids and cardiovascular disease
por: Tacconelli, Stefania, et al.
Publicado: (2014)

Hydrogen Sulfide Attenuated Angiotensin II-Induced Sympathetic Excitation in Offspring of Renovascular Hypertensive Rats
por: Feng, Xiaohong, et al.
Publicado: (2020)

Pharmacological manipulation of arachidonic acid-epoxygenase results in divergent effects on renal damage
por: Li, Jing, et al.
Publicado: (2014)

Gallic Acid Attenuates Angiotensin II-Induced Hypertension and Vascular Dysfunction by Inhibiting the Degradation of Endothelial Nitric Oxide Synthase
por: Yan, Xiao, et al.
Publicado: (2020)

Pharmacological Blockade of Soluble Epoxide Hydrolase Attenuates the Progression of Congestive Heart Failure Combined With Chronic Kidney Disease: Insights From Studies With Fawn-Hooded Hypertensive Rats
por: Vacková, Šárka, et al.
Publicado: (2019)

Potassium Intake Prevents the Induction of the Renin-Angiotensin System and Increases Medullary ACE2 and COX-2 in the Kidneys of Angiotensin II-Dependent Hypertensive Rats
por: Gonzalez, Alexis A., et al.
Publicado: (2019)

Neohesperidin Protects Angiotensin II-Induced Hypertension and Vascular Remodeling
por: Zhang, Jingsi, et al.
Publicado: (2022)

14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) Surrogates: Carboxylate Modifications
por: Falck, John R., et al.
Publicado: (2014)

Correction to 14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) Surrogates: Carboxylate Modifications
por: Falck, John R., et al.
Publicado: (2014)

Editorial: Renal Function in Acute and Chronic Kidney Diseases
por: Imig, John D., et al.
Publicado: (2020)

Elevated Aminopeptidase P Attenuates Cerebral Arterial Responses to Bradykinin in Fawn-Hooded Hypertensive Rats
por: Khan, Md Abdul Hye, et al.
Publicado: (2015)

Endogenous CCN5 Participates in Angiotensin II/TGF-β(1) Networking of Cardiac Fibrosis in High Angiotensin II-Induced Hypertensive Heart Failure
por: Huang, Anan, et al.
Publicado: (2020)

Blocking VCAM-1 Prevents Angiotensin II-Induced Hypertension and Vascular Remodeling in Mice
por: Yin, Liangqingqing, et al.
Publicado: (2022)

Qingda Granule Attenuates Angiotensin II-Induced Renal Apoptosis and Activation of the p53 Pathway
por: Long, Linzi, et al.
Publicado: (2022)

Cannabinoid receptor agonist attenuates angiotensin II–induced enlargement and mitochondrial dysfunction in rat atrial cardiomyocytes
por: Altieri, Danielle I., et al.
Publicado: (2023)

Angiotensin II Receptor Blockers but Not Angiotensin-Converting Enzyme Inhibitors Are Associated With a Reduced Risk of Acute Kidney Injury After Major Surgery
por: Yang, Shao-Yu, et al.
Publicado: (2021)

Effects of angiotensin II receptor blockers on serum levels of epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids in patients admitted to a cardiovascular center
por: Kato, Yuka, et al.
Publicado: (2021)

Angiotensin (1-7) Attenuates Sepsis-Induced Acute Kidney Injury by Regulating the NF-κB Pathway
por: Zhu, Ying, et al.
Publicado: (2021)

Angiotensin II Receptor Blocker Associated With Less Outcome Risk in Patients With Acute Kidney Disease
por: Wu, Vin-Cent, et al.
Publicado: (2022)

Qingda Granule Attenuates Angiotensin II-Induced Blood Pressure and Inhibits Ca(2+)/ERK Signaling Pathway
por: Wu, Meizhu, et al.
Publicado: (2021)

Chymase Dependent Pathway of Angiotensin II Generation and Rapeseed Derived Peptides for Antihypertensive Treatment of Spontaneously Hypertensive Rats
por: Baranowska, Iwona, et al.
Publicado: (2021)

Increased Endogenous Activity of the Renin-Angiotensin System Reduces Infarct Size in the Rats with Early Angiotensin II-dependent Hypertension which Survive the Acute Ischemia/Reperfusion Injury
por: Husková, Zuzana, et al.
Publicado: (2021)

The Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers on Clinical Outcomes of Acute Kidney Disease Patients: A Systematic Review and Meta-Analysis
por: Chen, Jui-Yi, et al.
Publicado: (2021)

The effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in critically ill patients with acute kidney injury: An observational study using the MIMIC database
por: Zhu, Xu, et al.
Publicado: (2022)

Correction to: Effects of angiotensin II receptor blockers on serum levels of epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids in patients admitted to a cardiovascular center
por: Kato, Yuka, et al.
Publicado: (2021)

The Glp-1 Analog Liraglutide Protects Against Angiotensin II and Pressure Overload-Induced Cardiac Hypertrophy via PI3K/Akt1 and AMPKa Signaling
por: Li, Ran, et al.
Publicado: (2019)

Effects of Angiotensin II Type 1A Receptor on ACE2, Neprilysin and KIM-1 in Two Kidney One Clip (2K1C) Model of Renovascular Hypertension
por: Alawi, Laale F., et al.
Publicado: (2021)

Altered Renal Vascular Responsiveness to Vasoactive Agents in Rats with Angiotensin II-Dependent Hypertension and Congestive Heart Failure
por: Vacková, Šárka, et al.
Publicado: (2019)

Editorial: Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
por: Imig, John D., et al.
Publicado: (2020)

A Novel Modulator of the Renin–Angiotensin System, Benzoylaconitine, Attenuates Hypertension by Targeting ACE/ACE2 in Enhancing Vasodilation and Alleviating Vascular Inflammation
por: Zhang, Qi-Qiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6l0ka1hsh8p961e4dhl5p8ar5t